Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Vital Signs:

This article was originally published in The Gray Sheet

Executive Summary

Vital Signs: Inks dual source supply agreement with Premier Purchasing Partners under which facilities participating in Premier's group purchasing program commit to buy at least 90% of selected anesthesia products, such as breathing circuits and face masks, from Vital Signs. To date, approximately 1,530 of Premier's 1,800 members have signed on to the program, the company says. Premier also announces an estimated $1 bil. sole- and dual-source purchasing deal with Baxter and Allegiance...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007154

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel